PPP1R3E Inhibitors

PPP1R3E inhibitors are a class of compounds that target and modulate the activity of the protein phosphatase 1 regulatory subunit 3E (PPP1R3E). PPP1R3E is part of the larger protein phosphatase 1 (PP1) complex, which plays a critical role in regulating glycogen metabolism by influencing the dephosphorylation of key enzymes involved in glycogen synthesis and degradation. Specifically, PPP1R3E is a glycogen-targeting subunit, meaning that it directs the PP1 catalytic subunit to glycogen particles within cells, thereby modulating the activity of glycogen synthase and phosphorylase enzymes. Inhibiting PPP1R3E results in the disruption of this targeting mechanism, potentially altering the fine-tuned regulation of glycogen synthesis and breakdown, which can have a cascade effect on cellular energy homeostasis and metabolic processes.

Structurally, PPP1R3E inhibitors tend to be designed to interact with the specific domains of the regulatory subunit that are responsible for binding glycogen and associating with the PP1 catalytic core. This often involves inhibitors mimicking or blocking key protein-protein interaction sites or preventing the assembly of the active PP1 complex. The complexity of these interactions requires a high degree of specificity in inhibitor design, as targeting the PPP1R3E subunit without affecting other components of the PP1 holoenzyme is critical for achieving selective inhibition. The exact structure-activity relationships (SARs) of PPP1R3E inhibitors can vary, but research often focuses on small molecules or peptides that can achieve high binding affinity for the regulatory subunit while maintaining stability and solubility under physiological conditions. Detailed understanding of the three-dimensional structure of PPP1R3E and its interaction partners has facilitated rational design approaches to these inhibitors, aiding in the exploration of the biochemical pathways influenced by PPP1R3E.